Gestational carrier pregnancy

Fertility and Sterility
S L CorsonM E English

Abstract

To evaluate the results of a gestational carrier program in terms of pregnancy rates in fresh and cryopreserved cycles. Retrospective analysis. Private IVF program. Women with uterine or medical reasons for unsuccessful gestation. In vitro fertilization of oocytes with fresh or cryopreserved ET to gestational carriers. Pregnancy rates and deliveries. A PR of 56.3% and a cycle rate of 30.8% was achieved in each patient <40 years of age in 117 cycles of fresh or cryopreserved ET. There were no pregnancies for nine patients >40 years of age in 27 cycles. Carrier gestation offers a satisfactory solution to childlessness caused by uterine or major medical factors.

References

Aug 1, 1992·Journal of Assisted Reproduction and Genetics·A M Braverman, S L Corson
Jan 1, 1991·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·M E EnglishS L Corson

❮ Previous
Next ❯

Citations

Mar 8, 2005·Fertility and Sterility·Deirdre A DuffyClaudio A Benadiva
Feb 14, 2007·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Dan R Reilly
Oct 11, 2015·Human Reproduction Update·Viveca Söderström-AnttilaChristina Bergh
Apr 19, 2016·Fertility and Sterility·Kiran M PerkinsUNKNOWN National Assisted Reproductive Technology Surveillance System (NASS) Group
Jul 1, 2013·Open Journal of Obstetrics and Gynecology·Raymond M AnchanElizabeth S Ginsburg
Jul 2, 2020·Human Fertility : Journal of the British Fertility Society·Jutharat AttawetElizabeth A Sullivan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.